Biotech firm Novavax Inc. $NVAX gained more than 11% during the Wednesday 11/28 session. This bump is pushing NVAX back into a bullish mode after a period of consolidation in the past month.NVAX Daily Chart(click to enlarge)Bullish Signs in Recent Months:- General market risk notwithstanding, Novavax looks bullish since finding a low on the year in August around $1.15 per share.- Since then, the market completed a price bottom and then shot up in late September towards almost $2.20. - Note that this rally was accompanied by relatively strong volume. - Then, the fact that price held above the cluster of moving averages suggests that this was a strong bullish stand.- Furthermore, the RSI pushed above 70, which indicated reemergence of bullish momentum. Then, the RSI holding above 40 suggested maintenance of the new established bullish momentum.- Now, if price clears above $2.00, we could be looking at another 10% rally to $2.20 in the near-term.- After that, the market might get choppy again, but if it can hold above $1.80, there should be upside towards the $2.75 high on the year in the medium-term (or until market risk appetite picks up) again.